Clinical trial
Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine
NCT00483717 · Egalet Ltd, Industry · Completed
Key facts
| NCT number | NCT00483717 |
|---|---|
| Title | Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine |
| Official title | A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, and Analgesic Efficacy of Ketorolac Tromethamine Administered Intranasally for the Acute Treatment of Migraine |
| Lead sponsor | Egalet Ltd, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | Ketorolac tromethamine, Placebo |
| Enrollment | 173 |
| Start date | Jul 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jun 7, 2007 |
| Last update posted | Sep 30, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: